Latest News About Eli Lilly And Company

Here are the latest publicly reported updates on Eli Lilly and Company:

• Lilly expands U.S. manufacturing footprint: The company announced a multi-year, multi-billion-dollar plan to boost domestic production, including new sites and job creation to strengthen supply chains for key medicines. This aligns with efforts to increase U.S. drug availability and reduce imports.

• Pipeline and drug updates: Lilly reported progress on its diabetes and obesity therapies, along with updates on cardiovascular and oncology programs. Market activity around its obesity and weight-management portfolio remained a key focus for investors.

• Financial results and strategic moves: Lilly disclosed quarterly earnings improvements driven by strength in core franchises, with ongoing investments in acquisitions and partnerships to broaden its pipeline and address pricing pressures.

• Notable acquisitions and partnerships: The company completed or announced acquisitions and collaborations with biotech and gene-editing firms to diversify its portfolio beyond weight-loss and diabetes therapies.

• Regulatory and pricing updates: Lilly has faced pricing scrutiny in various markets and has engaged with policymakers to address pricing and access concerns, while pursuing faster regulatory pathways for certain indications.

If you’d like, I can pull the most recent press releases or recent news articles and summarize them with dates and key figures. I can also filter by region (U.S. vs international) or by topic (pipeline, finances, regulatory).